In what passes for a short hearing these days in Washington, DC, the Trump White House’s pick to run the Food and Drug Administration, Scott Gottlieb, spent less than three hours fielding questions from a Senate committee Wednesday morning.
Amid predictable... Read more »
Is a caution flag flying?
While U.S. venture firms refueled last year by raising a near-record $51.6 billion, they also eased off the throttle in terms of their investment activity during the first quarter of 2017, according to data released... Read more »
As far as singular weeks go for biotech, this was a big one. Three highly anticipated drugs were approved. One is the first injectable medication for eczema. Another might help fend off the recurrence of ovarian cancer. And a third offers... Read more »
An ovarian cancer drug from Tesaro has won FDA approval ahead of schedule, adding a third treatment to a new group of therapies that work by blocking a process that tumors use to repair themselves.
Waltham, MA-based Tesaro (NASDAQ: TSRO)... Read more »
When Cool Planet found a lukewarm market for its renewable fuel, the startup needed to change course. Now focused on agriculture, Greenwood, CO-based Cool Planet is aiming for the market again—this time with a soils supplement backed by $19.3 million in... Read more »
Who knew healthcare could be so complicated? This week, President Trump and the GOP saw first hand, as a feverish rally to get their healthcare bill through the House of Representatives on Thursday stalled before a vote. Elsewhere in Washington... Read more »
It’s been more than a year since an infamous party with hired models in cocktail dresses captured the biotech community’s attention at the 2016 J.P. Morgan conference.
There has been plenty of talk since about closing biotech’s notable gender gap. At... Read more »
Year after year, Xconomy has gathered exemplary business leaders, investors, and far-seeing technologists to our most prestigious event—The Napa Summit. This year is no different. Come join us in the heart of wine country on June 8 and 9... Read more »
I hit the airwaves Friday morning to talk venture capital, startups, self-driving cars, and March Madness.
Stocks and Jocks, a Chicago-based weekday business and sports talk radio program, invited me on the show to share my thoughts on some of... Read more »